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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S272Methods: Our gel-free proteomics approach includes tissue extraction,
digestion by trypsin and reversed phase separations coupled to tandem
mass spectrometry for the identiﬁcation and targeted quantiﬁcation of
peptides by multiple reaction monitoring (MRM). The tissue was sliced
from synovial surface to bone in 10mm thin sections and the full
thickness cartilage was divided into 100mm pools including superﬁcial,
intermediate and deep zones.
Results: Previous known distribution of proteoglycan 4 (PRG4, lubricin,
superﬁcial zone protein) was conﬁrmed but also novel ﬁndings were
observed e.g. asporin which was predominantly present in the super-
ﬁcial layers. In total 40 proteins were quantiﬁed showing distinct
patterns in normal tissue. In addition we observed altered protein
distribution patterns in preclinical (macroscopically normal) tissue
from a joint with early ﬁbrillation (OA-lesions) on the opposite surface.
Conclusions: As an alternative to immunohistochemistry we used
proteomics technology to study the protein abundance across full
thickness articular cartilage. The advantages of this approach are that it
allows multiple targets to be studied simultaneously, it is independent
of antibody availability and circumvent some antibody-related artifacts.
Other advantages include unambiguous identiﬁcations and improved
quantiﬁcations. The work shows novel information on the differences
that exist in different layers of cartilage that is of value in understanding
changes in early pathology.
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Purpose: Biomarkers of cartilage inﬂammation and degradation can
provide information about the pathogenesis of arthritic diseases such as
osteoarthritis (OA), allowing earlier diagnosis, improved monitoring,
and mechanistic insight into OA progression. Utilizing high-throughput
proteomics approaches, this study aimed to identify and quantitatively
compare proteins that respond to pro-inﬂammatory (IL-1b) and anti-
inﬂammatory (carprofen) stimuli in the secretome of articular cartilage.
Methods: Articular cartilage was harvested from equine meta-
carpophalangeal joints from horses euthanized for purposes other than
research. Explant cultures were established and treated as follows:
untreated (control) media alone, pro-inﬂammatory cytokine IL-1b (10
ng/ml), the COX-2 speciﬁc non-steroidal anti-inﬂammatory drug
(NSAID) carprofen (100 mg/ml) or IL-1b + carprofen. After 6 days incu-
bation (37C, 5% CO2) media were collected for downstream analysis,
using a combination of SDS-PAGE, silver staining, high-throughput
nanoLC-MS/MS on an amaZon speed ETD (Bruker) and quantitative
western blotting.
Results: High-throughput mass spectrometry identiﬁed cartilage
extracellular matrix (ECM) proteins (biglycan, ﬁbronectin, decorin,
COMP, collagen type II), secreted proteins related to cartilage mainte-
nance and turnover (MMP-1, -3 and -13, TIMP-1), along with inﬂam-
matory stress/molecular chaperone related proteins (HSP70, clusterin).
Qualitative differences in PCPE-2, frizzled related protein, HSP70, MMP-
1, -3 and -13 release were observed between untreated and cytokine
treated explant secretomes. Quantitative analysis by western blotting
conﬁrmed that carprofen treatment signiﬁcantly reduced IL-1b stimu-
lated release of MMP-1, -3 and -13. ECM proteins targeted by these
IL-1b-stimulated MMPs (i.e. ﬁbronectin) exhibited additional frag-
mentation patterns on western blots, which were reduced by carprofen
treatment.
Conclusions: Proteins differentially released in response to IL-1b
stimulationwithin this explant model may enable screening of new and
existing drugs and various natural compounds with anti-inﬂammatory
properties. This study revealed that carprofen, a COX-2 speciﬁc inhib-
itor, decreases the release of inﬂammatory-associated proteins and one
established BIPEDS marker of cartilage degradation in OA (MMP-3).
Carprofen-suppression of IL-1b-stimulated MMP-1, -3 and -13 release
may result in reduced ECM degradation indicating that this drug may
potentially reduce progression of degenerative cartilage loss and OA.
This interpretation of the data is supported by the reduction of IL-1b
stimulated ﬁbronectin degradation fragments released from the ECM.
Combining high-throughput analytical techniques such as proteomics
with this in vitro model of cartilage inﬂammation producesinterpretable data and may provide realistic alternatives to in vivo
animal models.530
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Purpose: Osteoarthritis (OA) is characterized by the loss of structural
components from the extracelullar matrix (ECM) of articular cartilage.
The release of these proteins from the tissue can vary according to the
stage of the disease. The aim of this study was to perform a proteomics
approach to identify and quantify those proteins released from normal
and OA human articular cartilage explants. Furthermore, we seeked to
differentiate those proteomic signatures displayed from the wounded
zones (WZ) from those corresponding to the area adjacent to the lesion,
or unwounded zones (UZ), in the OA samples. These proteins released
from cartilage might have a tissue-characteristic biomarker value for
early diagnosis and/or therapy monitoring.
Methods: Macroscopically articular cartilage was obtained from the
dissection of normal and OA femoral heads. The cartilage from normal
samples, and from WZ and UZ of the same OA piece, was cut into ﬁve
6mm2 explants. Then, these explants were washed in PBS and har-
vested in 96-well plates with 200mL of serum-free DMEM. The condi-
tioned media from each condition were collected at days 1, 3, 6 and
replaced with fresh medium. Media from each condition were quanti-
ﬁed, concentrated and precipitated O/N with acetone. Finally, proteins
were digested with trypsin and each peptide solution was labelled with
different isobaric tags using the iTRAQ reagents. The labelled peptides
of the different conditions weremixed, desalted and separated by HPLC.
The resulting fractions were grouped and resolved by reversed-phase
nanoliquid cromatography coupled to mass spectrometry. The identi-
ﬁcation and relative quantiﬁcation of the proteins was carried out with
Protein Pilot 3.0 software.
Results: Protein concentrations were higher in the culture media from
wounded zones than from unwounded zones of OA cartilage, due to the
increased degradation that is taking place in the lesion. We ﬁrst identi-
ﬁed several ECM proteins that were differentially released betweenWZ
and UZ in OA samples at two different times of culture. Most of them
were increased in the wounded tissue, including collagens (I, II, VI and
XV), proteoglycans (biglycan, lumican or perlecan) and proteins related
with cell adhesion (tenascins, osteomodulin or vitronectin). In a second
step, proteins released to themedia up today6of culturewere compared
between three conditions (WZ, UZ and normal tissue). This analysis led
to the identiﬁcation of 199 proteins, 110 of them quantitatively altered
between the conditions of the study. Interestingly, several proteinswere
differentially released already in the unwounded zone of OA cartilage
compared to the normal samples (osteopontin, matrilin-3, cartilage link
protein or transforming growth factor-beta-induced protein), and their
amounts do not seem to be increased in the WZ. Finally, a small set of
proteins, including thrombospondin-1 or type XVIII collagen,weremore
abundant in the media from N cartilage than from OA.
Conclusions: We have identiﬁed a proﬁle of proteins released from
diseased cartilage in OA. Our work describes a panel of cartilage-char-
acteristic proteins with potential biomarker value of the tissue degra-
dation process that takes place in the disease. This panel will be further
explored in biological ﬂuids (synovial ﬂuid and serum) for the devel-
opment of early diagnosis and/or therapy monitoring strategies.
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Purpose: The aim of this study was to develop bioinformatic methods
for the identiﬁcation of a minimum set of biomarkers present in the
